NCT00838578 2024-04-26Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerKyowa Kirin Co., Ltd.Phase 1/2 Terminated65 enrolled 7 charts
NCT03368859 2021-02-09A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and BevacizumabAbbViePhase 2 Terminated70 enrolled 12 charts
NCT02503631 2018-04-06Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersExact Sciences CorporationTerminated397 enrolled
NCT01134666 2017-06-09An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal CancerMerck KGaA, Darmstadt, GermanyTerminated165 enrolled